Price T Rowe Associates Inc Regenxbio Inc. Transaction History

Price T Rowe Associates Inc

  • $935 Billion
  • Q3 2025

A detailed history of Price T Rowe Associates Inc transactions in Regenxbio Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 38,992 shares of RGNX stock, worth $448,797. This represents 0.0% of its overall portfolio holdings.

Number of Shares
38,992
Previous 27,980 39.36%
Holding current value
$448,797
Previous $230,000 63.91%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
BUY
$7.46 - $9.89 $82,149 - $108,908
11,012 Added 39.36%
38,992 $377,000
Q2 2025

Aug 14, 2025
BUY
$5.31 - $10.4 $9,451 - $18,512
1,780 Added 6.79%
27,980 $230,000
Q1 2025

May 14, 2025
BUY
$5.92 - $8.7 $13,556 - $19,923
2,290 Added 9.58%
26,200 $188,000
Q4 2024

Feb 14, 2025
BUY
$7.23 - $11.56 $14,329 - $22,911
1,982 Added 9.04%
23,910 $185,000
Q3 2024

Nov 14, 2024
BUY
$10.49 - $14.39 $8,685 - $11,914
828 Added 3.92%
21,928 $231,000
Q2 2024

Aug 14, 2024
BUY
$11.51 - $21.53 $33,643 - $62,932
2,923 Added 16.08%
21,100 $247,000
Q1 2024

May 15, 2024
BUY
$12.17 - $24.61 $17,500 - $35,389
1,438 Added 8.59%
18,177 $383,000
Q4 2023

Feb 14, 2024
BUY
$12.89 - $20.82 $14,784 - $23,880
1,147 Added 7.36%
16,739 $301,000
Q3 2023

Nov 14, 2023
BUY
$16.46 - $19.99 $18,830 - $22,868
1,144 Added 7.92%
15,592 $257,000
Q2 2023

Aug 14, 2023
BUY
$17.23 - $21.71 $8,373 - $10,551
486 Added 3.48%
14,448 $289,000
Q1 2023

May 15, 2023
SELL
$18.08 - $24.55 $2.86 Million - $3.89 Million
-158,349 Reduced 91.9%
13,962 $265,000
Q4 2022

Feb 14, 2023
SELL
$20.4 - $24.73 $994,316 - $1.21 Million
-48,741 Reduced 22.05%
172,311 $3.91 Million
Q3 2022

Nov 14, 2022
BUY
$22.29 - $35.04 $25,544 - $40,155
1,146 Added 0.52%
221,052 $5.84 Million
Q2 2022

Aug 15, 2022
SELL
$19.35 - $35.04 $584,582 - $1.06 Million
-30,211 Reduced 12.08%
219,906 $5.43 Million
Q1 2022

May 16, 2022
SELL
$24.62 - $34.31 $1.55 Million - $2.17 Million
-63,139 Reduced 20.16%
250,117 $8.3 Million
Q4 2021

Feb 14, 2022
BUY
$30.19 - $40.28 $552,809 - $737,567
18,311 Added 6.21%
313,256 $10.2 Million
Q3 2021

Nov 15, 2021
BUY
$29.09 - $45.68 $428,437 - $672,775
14,728 Added 5.26%
294,945 $12.4 Million
Q2 2021

Aug 16, 2021
SELL
$32.46 - $40.48 $465,151 - $580,078
-14,330 Reduced 4.87%
280,217 $10.9 Million
Q1 2021

May 17, 2021
BUY
$33.61 - $49.95 $191,946 - $285,264
5,711 Added 1.98%
294,547 $10 Million
Q4 2020

Feb 16, 2021
BUY
$26.52 - $49.35 $7.66 Million - $14.3 Million
288,836 New
288,836 $13.1 Million

Others Institutions Holding RGNX

# of Institutions
189
Shares Held
44.3M
Call Options Held
138K
Put Options Held
117K
View Full List

About REGENXBIO Inc.

RGNX Quotes by TradingView
  • Ticker RGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,230,000
  • Market Cap $498M
  • Description
  • REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...
More about RGNX
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email